Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience
Crossref DOI link: https://doi.org/10.1007/s00280-015-2715-x
Published Online: 2015-03-06
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Petrioli, Roberto
Francini, Edoardo
Roviello, Franco
Marrelli, Daniele
Fiaschi, Anna Ida
Laera, Letizia
Rossi, Giulia
Bianco, V.
Brozzetti, S.
Roviello, Giandomenico
Text and Data Mining valid from 2015-03-06